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Hypercoagulable states are a group of conditions associated with an 
enhanced tendency toward blood clotting. Although usual clinical 
manifestations of hypercoagulable states are thrombotic events such as deep 
venous thrombosis, hematoma can also occur as a result of 
hypercoagulability in some patients. Several inherited or acquired 
conditions may lead to hypercoagulable states. Some of them 
includemyeloproliferative syndromes, over activity of coagulation factors 
and methyl tetrahydrofolate reductase (MTHFR) polymorphisms. MTHFR 
is required for converting the amino acid homocysteine to methionine. 
Another significant role of an aptly functioning MTHFR enzyme is nucleic 
acid biosynthesis. Therefore MTHFR polymorphisms are expected to be 
associated with hypersegmentation of neutrophils because of a defect in 
DNA metabolism. Neutrophil hypersegmentation is one of the most 
sensitive hematological features of cobalamin or folate deficiency with 
normal serum vitamin B12-folic acid and iron levels. Hypersegmentation of 
neutrophils and hematoma or both of them suspected to be due to gene 
variations of MTHFR.  
Here we report a 37-years old female who simultaneously affected by 
hereditary hypersegmentation and extensive hematoma. Laboratory analysis 
revealed normal serum vitamin B12, folic acid and iron levels. Routine and 
specific coagulation tests were normal in except of factor VIIIc that was 
high. Results of complete blood cell count (CBC) test were normal. 
Although this is just an idea, but simultaneous presentations of these two 
conditions can have a common origin. 
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Hypercoagulable states can be defined as a 
group of conditions associated with an 
enhanced tendency toward blood clotting in the veins 
or arteries. Hypercoagulability, also known as 
thrombophilia, can result from several inherited and 
acquired conditions such as deficiencies in protein C, 
protein S, or antithrombin III, overactivity of 
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coagulation factors, antiphospholipid syndrome, 
inflammation and obesity (1-3). Polymorphisms of 
methylene tetrahydrofolate reductase (MTHFR) gene 
are also associated with an increased risk of heritable 
thrombophilia (4, 5). MTHFR gene produces the 
enzyme that plays an important role in amino acids 
processing, particularly the conversion of 
homocysteine to methionine. Two common 
polymorphisms in MTHFR gene including C677T 
and A1298C, lead to decreased enzyme activity and 
therefore elevation of homocysteine level. C667T 
exists in the MTHFR gene that encodes the catalytic 
domain of the MTHFR enzyme, in which a C>T 
substitution at position 677 results in a substitution of 
alanine to valine .The single amino acid substitution 
results in impaired folate binding and reduced activity 
of the MTHFR enzyme (6-8). Heterozygotes carrying 
this thermolabile variant have a reduced enzyme 
activity to 65% of normal, while homozygotes have 
only 30% of normal activity (9). It is found in 
homozygous state in 10% of the population and both 
forms of homozygotes and heterozygotes, cause 
elevated levels of plasma homocysteine (10). 
However usual clinical manifestations of 
hypercoagulable states are thrombotic events such as 
deep venous thrombosis (DVT) which are reported in 
associated with MTHFR polymorphisms (11), 
hematoma is also mentioned as a result of 
hypercoagulability in some patients. It is suggested 
that the presence of a hematoma may be the first 
indicator of an underlying thrombophilia (12). 
MTHFR plays a central role in folate metabolism via 
converting 5,10-methylenetetrahydrofolate to 5-
methylenetetrahydrofolate that is the primary 
circulating form of folate and is vital for DNA 
synthesis. Polymorphism in MTHFR and other genes 
which play a role in folate metabolism may lead to 
deficient DNA synthesis and probably to neutrophil 
hypersegmentation (13). Coexistence of MTHFR 
polymorphism and hypersegmented neutrophils was 
reported in patients with hemolysis and cobalamin 
deficiency (14). 
Brief Report 
A 37-years old female was refer with extensive 
hematoma of both forearms. Initially routine and a 
number of specific coagulation tests including 
prothrombin time (PT) and activated partial 
thromboplastin time (aPTT), protein C and protein S 
as well as antithrombin III (ATIII) activity were 
performed. Factor VIII activity (FVIII:C) also was 
measured. All of these tests were performed by ACL 
top 300-autoanalyzer (Instrumentation Laboratory, 
Milan, Italy) (Table 1). 
Discussion 
NPC is caused by mutations in one of the two 
genes called NPC1 or NPC2. 95% of cases have 
NPC1 mutation which encodes a large glycoprotein in 
 
Fig. 1.Hypersegmented neutrophils in peripheral smear. (a) Patient blood smear. (b) Patient’s mother blood 
film Examination of peripheral blood films of patient and her mother reveals 4% neutrophils with more than 
five nuclear lobes and 12% neutrophils, having five nuclear lobes in patient and 6% neutrophil with five 
nuclear lobes in patient’s mother. 
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late endosomal location. This gene mapped to 
chromosome 18q11-q12, spans 56 kbp and contains 
25 exons. NPC2 encodes a small soluble lysosomal 
protein which binds cholesterol with high affinity (8). 
NPC2 mapped to chromosome 14q24.3, spans 13.5 
Kbp and contains 5 exons. Deficiency in both types 
causes impairment in processing and utilization of 
endocytosed cholesterol (1, 8). The cellular hall mark 
of this disease is inability of cholesterol to transport 
from late endosomes to plasma membrane or 
reticulum endoplasmic therefore accumulation of 
cholesterol and products will occur (Figure 1) (1). 
Therefore cholesterol storage is impeded and 
resulted in a different pattern of accumulation in 
neuronal and extra-neuronal tissues. These changes 
cause sphingomyelin metabolism alteration in extra 
neuronal tissues. Unesterified cholesterol, 
sphingomyelin, bisphosphate, glycolipids, and free 
sphingosine and sphinganine will accumulate in liver 
and spleen (1). In neurons, accumulation of 
Glycosphingolipids including GM2 and GM3 
gangliosides occurs and cause meganeurite formation, 
growth of ectopic dendrites, neurofibrillary tangles 
Table 1:Results of Routine and specific 
coagulation tests. 
 
Test Result Normal range 
PT 10.5 9.5-12.5 sec 
aPTT 27.2 24.9-29.1 sec 
FVIII.C 162 60-150 (%) 
ATIII 100 80-120 (%) 
PC 84% 70-140 (%) 
PS 103 60-135.5 (%) 
Fibrinogen 345 220-496 
 
PT: Prothrombin time, aPTT: activated partial 
thromboplastin time, PS: Protein S, PC: Protein C, 
ATIII:Antithrombin III activity , FVIII:C: Factor VIII 
activity, Sec: seconds 
Table 2: Complete blood cell count (CBC) results of patients with extensive hematoma and heredity 
neutrophil hypersegmentation. 
Index Result Unite Interpretation 
WBC 7000 /ul Normal 
RBC 3760000 /ul Low 
Hemoglobin 11.8 g/dl Low 
Hematocrit 33.6 % Normal 
MCV 89.4 Fl Normal 
MCH 31.4 Pg Normal 
MCHC 35.1 g/dl Normal 
Platelet 192000 /ul Normal 
Neutrophil% 55% % Normal 
Lymphocyte% 37% % Normal 
Monocyte% 2% % Normal 
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formation, neuroinflammation, and neuroaxonal 
dystrophy (8). On the other hand, some proteins like 
Rab9 or mannose-6-phosphate receptors transfer to 
cell membrane by late lysosomal system. Cholesterol 
accumulation could also impair this trafficking (1). 
Unexplainably neural death occurs mostly in Purkinje 
cells of the cerebellum. The function of these proteins 
are not defined yet so the exact mechanism and 
pathophysiology remains a mystery (1). 
The only approved therapy for NPC so far is 
Miglustat (N-butyl-deoxynojirimycin). It is an 
iminosuger inhibitor of glucosylceramide synthase 
(1). This drug can stabilize the neurological 
manifestations including dysphagia (6). Miglustat by 
inhibiting glucosylceramide synthase reduce the 
synthesis of glucosylceramide-based glycosphin-
golipid in CNS (6). But long term clinical outcomes 
are still unclear (6). Other drugs used for symptom 
therapy including antiepileptic drugs (treatment of 
seizure), clomipramine, protriptyline, or modafinil 
(treatment of Cataplexy), anticholinergic agents 
(treatment of dystonia and tremor), Melotonin 
(treatment of insomnia). Physiotherapy for 
management of muscle spasticity and contracture is 
useful. As the major cause of mortality in these 
patients is aspiration pneumonia, the most important 
part of managing this disease is handling feeding 
abnormalities (1, 6). Current researches in the field of 
treating this disease is based on animal models mostly 
transgenic mice and cats and also testing various 
compounds like imatinib, curcumin, NSAIDs, 
neurosteroids (allopregnolone) and 2-HP-ß-
cyclodextrin. The last compound showed significant 
improvement in disease natural history in animal 
models but needs further investigations (1). 
The exact function of NPC genes are unknown 
therefore the pathophysiology of this disease is still a 
mystery (4). So the target metabolite in brain causing 
the neuroinflammatory responses remains unknown. 
These results are in lack of a biochemical blood test 
for evaluating prognosis or diagnosis (1, 4). Currently 
the gold standard for diagnosis is skin biopsy however 
recent advances suggest oxysterol profile as a 
biomarker for NPC. Although more researches are 
needed to define it as an indicator, these findings 
could change the future treatment and research 
developments (1, 4). 
As mentioned above, NPC is a disease which 
involves multiple organs including central nervous 
system, respiratory system and gastrointestinal system 
(hepatosplenomegaly). Therefore this disease could 
interfere with routine anesthetic plans (3, 5). 
Restrictive lung disease arise from recurrent 
aspirations demand specific consideration in 
ventilator setup, so lower tidal volumes and increase 
in respiratory rate could be helpful for these patients. 
Another problem is the liver damage caused by 
storage of lipids, which needs careful selection of 
anesthetic drugs (5). Also hepatomegaly could 
accompany ascites which leads to decreased 
Functional Residual Capacity (3). there are some 
reports indicating the association between NPC and 
difficult airway therefore considering options for 
intubation would be wise (1). on the other hand, 
thrombocytopenia accompanied by this disease, could 
potentiate the risk of bleeding (1). Due to vigorous 
secretions anticholinergic drugs prior to anesthesia 
could improve the outcome of the procedure (3). It is 
demonstrated that hyperventilation plus high 
concentrations of Sevoflurane could induce seizures. 
Therefore to avoid this phenomenon continuing 
antiepileptic agents in perioperative period and use of 
TIVA instead of volatiles is recommended (3). The 
technique of choice is the one in which satisfactory 
condition for procedure is established rapidly and 
safely and also the recovery should be safe and 
predicted with minimal sequel for the patient (5). 
Then a complete blood cell count (CBC) was 
performed using an automated counting device 
(Sysmex KX-21, SYSMEX, Japan). All blood cell 
indices were normal in except of a mild anemia with 
decreased red blood cell (RBC) count (Table 2). 
All blood cell indices were normal except red 
blood cell (RBC) count and hemoglobin 
concentration. Both are less than the normal range. 
Patient was treated with folic acid and iron 
supplement for more than 3 months before laboratory 
analyses. The patient's serum vitamin B12, folic acid 
and homocysteine concentrations were 24.8pg/ml, 
12.02ng/ml and 13µmol/l, respectively. All of them 
were in normal range according to age and sex. Serum 
iron was also measured in order to determine possible 
cause of neutrophil hypersegmentation. The serum 
iron was 80μg/dL, it was normal. 
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Conclusion 
Neutrophil hypersegmentation is an expected 
finding in folate and vitamin B12 deficiency (15, 16). 
There are several reports about present of neutrophil 
hypersegmentation in patients with iron deficiency 
(17, 18). This female had neutrophil 
hypersegmentation with normal serum iron and folate 
as well as vitamin B12. 
Normal gene variations in MTHFR gene can 
alter folate metabolism and subsequently defective 
DNA synthesis (13). In the other hand this common 
gene variations have a strong relationship with 
hypercoagulability and several studies showed 
various signs of hypercoagulable states in different 
patients (19, 20) . Although hematoma is a common 
presentation in patients with bleeding but in 
hypercoagulable states hematoma was also reported 
(12, 21). A hematoma is a collection of blood, usually 
clotted, outside of a blood veins that may occur 
because of an injury to the wall of a blood veins 
allowing blood to leak out into tissues where it does 
not belong. The damaged blood vessel may be an 
artery, vein, or capillary (22-24). 
In this patient only FVIIII: C is moderately 
increased and other signs of hypercoagulability are 
absent but gene variations of MTHFR also can be 
accompanied by normal level of homocysteine in 
vascular events (25). In the current case, presence of 
heredity hypersegmentation can be suggestive of a 
defect in DNA metabolism. This defect in DNA 
synthesis can also provokes coagulation activity and 
therefore hypercoagulability associated presentations 
(26-28). Neutrophil hypersegmentation may also be 
accompanied by other conditions such as 
thrombocytosis that was reported with normal folate 
and vitamin B12 serum levels (17). Neutrophil 
hypersegmentation with folic acid deficiency was 
reported in pregnancy but this situation is transient 
and is solved several weeks after delivery (29). This 
case was not pregnant and her neutrophil 
hypersegmentation was not transient. Since neutrophil 
hypersegmentation is an autosomal dominant disorder 
(30) we assessed patient’s mother for presence of 
hypersegmented neutrophils and we found 6% 
neutrophil with five nuclear lobes in her blood film 
(Figure 1). Neutrophil hypersegmentation is defined 
as any neutrophil having six or more nuclear lobes or 
more than 3% of neutrophils having five nuclear 
lobes, when 100 neutrophils are examined (ICSH 
recommendations for the standardization of 
nomenclature and grading). This case emphasized that 
neutrophil hypersegmentation can be accompanied by 
hypercoagulability. This situation can be a genetically 
disorder or acquired state, but according to this case, 
this situation seems to be due to a gene defect in 
folate metabolism but further studies are required. 
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